Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation | |
---|---|---|
D012877 | Skin Manifestations NIH | 1.00 |
D002647 | Chilblains NIH | 0.58 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
COVID-19 (SARS-CoV-2) infection in health professionals represent a significant criticality both for the risk of spreading the disease and for the organizational aspects that follow. The objective of the study is to evaluate the spread of COVID-19 virus within the hospital population of Humanitas through the monitoring of the levels of IgG antibodies. Moreover, viral load will be measured by RT-PCR in the subgroup positive to IgG antibodies.
Description: Measurement of the temporal trend of the antibody value of anti-SARS-CoV-2 neutralizing IgG.
Measure: SARS-CoV-2 levels of IgG antibodies Time: 1 yearDescription: Measurement of the viral load of the nasopharyngeal swab in antibody test positive subjects and the correlation between the antibody titer and virus positivity or negativity.
Measure: SARS-CoV-2 viral load in nasopharyngeal swab of IgG positive subjects Time: 1 yearDescription: The association between the antibody value and potential protective or risk factors of the subject participating in the study such as age, clinical history, vaccination history, workplace, professional category, etc.
Measure: Epidemiology correlations Time: 1 year